GE HealthCare Technologies GEHC Imaging — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by GE HealthCare Technologies in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about GE HealthCare Technologies's imaging — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is GE HealthCare Technologies's imaging — D&A?
- GE HealthCare Technologies (GEHC) reported imaging — D&A of $54M in Q1 2026.
- How has GE HealthCare Technologies's imaging — D&A changed year-over-year?
- GE HealthCare Technologies's imaging — D&A decreased by 5.3% year-over-year, from $57M to $54M.
- What is the long-term trend for GE HealthCare Technologies's imaging — D&A?
- Over 3 years (2022 to 2025), GE HealthCare Technologies's imaging — D&A has grown at a -7.0% compound annual growth rate (CAGR), from $282M to $227M.
- What does imaging — D&A mean?
- The non-cash expense allocated to the Imaging segment for the wear and tear of tangible assets and the amortization of intangible assets like patents or acquired technology. This metric reflects the capital intensity of the segment's operations. It is a critical component for calculating EBITDA and understanding the segment's ongoing capital reinvestment needs.